| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44f04d319aaa6e66f240244bc905f452
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5ad8562c578b061df7a2c3aee9d0e24 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-403 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-065
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-062 |
| filingDate |
2017-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2019-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba5d9c568561425fb00fdb004e15fbba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5a4c26afd2489b9d789a9fd22813b91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd8dc1eea6752de93aac930d64d1b791
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b13b9eb0704cafde1a47a1b8a1bfc0e1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9106a4e1e8f5423ef6196f9796fd3f50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47619de538a56e8fed994706a5f44658
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1dc2533ab92c047e863555448b2aeb34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52efe0279faf673cabb626055beb6a08 |
| publicationDate |
2019-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-10421779-B2 |
| titleOfInvention |
Carbazole compound having anti-virus activity |
| abstract |
The present invention relates to a carbazole compound having anti-virus activity, and more particularly, to a novel compound selected from the group of consisting of a carbazole compound which shows excellent anti-proliferative efficacy against hepatitis C virus (HCV), a pharmaceutically acceptable salt thereof, a hydrate thereof, and an isomer thereof; an anti-virus pharmaceutical composition including the novel compound as an active ingredient; a pharmaceutical composition for preventing or treating liver diseases caused by hepatitis C virus; and a method of preparing the novel compound. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11261175-B2 |
| priorityDate |
2016-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |